1Y Close · As of Aug 26, 2026
HK inno.N operates in the Pharmaceuticals sector.
Legal name: HK inno.N Corporation
In fiscal year 2021, HK inno.N (195940) reported revenue of 769.8 billion KRW, up 28.6% from 598.4 billion KRW a year earlier.
Operating profit was 50.3 billion KRW and net income was 24.7 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 1.24 trillion KRW, with a P/B of 0.93.
These figures can be verified in the DART filing (receipt no. 20260318000705).
Recent Filings
Payment and Dispute Resolution
Semi-Annual Report (2026.06)
Extraordinary Meeting Result
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Payment and Dispute Resolution |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-12 | Extraordinary Meeting Result |
| 2026-08-12 | Independent Director Change Report |
| 2026-07-29 | Corporate Briefing (IR) |